在麻醉和重症监护中使用抗生素
Antoine Premachandra1, Pierre Moine1,2,3
1Department of Intensive Care, Hôpital Raymond Poincaré, Groupe Hospitalo-Universitaire GHU AP-HP, University Versailles Saint Quentin-University Paris-Saclay, Garches, France.
败血症管理需要谨慎使用抗微生物药物,以减少死亡率和预防耐药性. 优化抗生素治疗,考虑到手术部位感染和微生物群影响等因素,对于患者的治疗结果至关重要.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症是一个全球性的健康危机,每年造成数百万人的死亡.
- 抗菌药物对于败血症治疗至关重要,但存在诸如副作用和耐药性等风险.
- 不适当的抗生素使用,无论是不充分的还是过于广泛的,都会增加死亡率,并选择耐药细菌.
研究的目的:
- 审查影响手术部位感染和外科手术期间抗生素预防的因素.
- 总结了在重症监护病房优化抗生素治疗方面的进展.
- 讨论微生物群的作用和抗菌素的影响.
主要方法:
- 对当前文献和专家建议进行叙述性审查.
- 关于药理动力学/药理动力学 (PK/PD) 原则的讨论.
- 分析影响手术部位感染和外科手术期间抗生素预防的因素.
主要成果:
- 详细介绍了手术部位感染的风险因素和外科手术期间抗生素预防的考虑因素.
- 介绍了优化重症监护病房抗生素治疗的最新策略.
- 强调了抗微生物药物对微生物群的重大影响和耐药性的出现.
结论:
- 在败血症中优化抗生素治疗需要一种细微的方法,平衡疗效与耐药性的风险.
- 了解PK/PD原则对于管理复杂患者和尽量减少多药耐药生物体的出现至关重要.
- 整合有关手术部位感染,重症监护室治疗和微生物群影响的知识是改善败血症结果的关键.
更多相关视频
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
相关概念视频
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Cleaning, Sterilization, and Disinfection
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
